GGrantIndex
Sort

172,184 grants matching inflammation

Mechanisms of Effective Humoral Immune Responses to HIV-1

$1,230,841
Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS)

$1,230,812
Thomas L Vaughan · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA

Center on Intersystem Regulation by Drugs of Abuse

$1,230,624
Ellen M Unterwald · Temple Univ Of The Commonwealth · P30 · FY2012 · DA

THE PHAGOCYTE MEMBRANE

$1,230,418
Massachusetts General Hospital · P01 · FY2001 · DK

IND-enabling toxicology studies to reach IND approval for a proprietary biologic to treat oral mucositis in cancer patients

$1,230,285
Christian Young · Allander Biotechnologies, Inc. · SB1 · FY2024 · DE

Biodefense Proteomics Collaboratory

$1,230,272
University Of Texas Medical Br Galveston · U01 · FY2004 · AI

Research Center for Pharmacology and Drug Toxicology

$1,230,188
Vanderbilt University · P50 · FY2004 · GM

Characterization of the molecular mechanisms of LC3-associated phagocytosis and its role in disease pathogenesis

$1,230,164
Jennifer Martinez · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES

THE PHAGOCYTE MEMBRANE

$1,230,133
Massachusetts General Hospital · P01 · FY2004 · DK

Cystic Fibrosis Translational Research in the Post-CFTR Modulator Era

$1,230,099
Bonnie W Ramsey · Seattle Children'S Hospital · P30 · FY2020 · DK

Center for Interdisciplinary Study of Inflammatory Intestinal DIsorders (C-IID)

$1,230,000
Bana Jabri · University Of Chicago · P30 · FY2021 · DK

Center for Interdisciplinary Study of Inflammatory Intestinal DIsorders (C-IID)

$1,230,000
Eugene B Chang · University Of Chicago · P30 · FY2024 · DK

Center for Interdisciplinary Study of Inflammatory Intestinal DIsorders (C-IID)

$1,230,000
Bana Jabri · University Of Chicago · P30 · FY2022 · DK

Center for Interdisciplinary Study of Inflammatory Intestinal DIsorders (C-IID)

$1,230,000
Bana Jabri · University Of Chicago · P30 · FY2023 · DK

An unbiased OMICs approach to identify mechanisms of Cocaine regulation of the HIV reservoir.

$1,229,898
Rafick-Pierre Sekaly · Case Western Reserve University · R01 · FY2016 · DA

The Columbia University Digestive and Liver Disease Research Center

$1,229,895
Robert F. Schwabe · Columbia University Health Sciences · P30 · FY2022 · DK

In-vitro and Pre-clinical Translational Studies of Inflammation and Atherosclerosis

$1,229,879
Nehal Mehta · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL

Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis

$1,229,878
William James Adams · Riparian Pharmaceuticals, Inc. · R44 · FY2017 · HL

Research Project 1: In vitro and in vivo assessment of flavorant toxicity

$1,229,573
Irfan Rahman · Roswell Park Cancer Institute Corp · U54 · FY2019 · CA

Development of New Improved Perflutren Ultrasound Contrast Agent

$1,229,385
Wyatt Daniel Unger · Microvascular Therapeutics, Llc · R44 · FY2017 · HL

THE PET RADIOTRACER TRANSLATION AND RESOURCE CENTER (PET-RTRC)

$1,229,306
Robert J Gropler · Washington University · P41 · FY2021 · EB

Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial

$1,229,055
Nisha Acharya · University Of California, San Francisco · UG1 · FY2023 · EY

Effect of Microbicides on Mucosal HIV Transmission

$1,228,872
University Of California Davis · R01 · FY2004 · AI

Follow-Up Studies of a Genome-Wide Association Analysis in Pima Indians

$1,228,825
Leslie J Baier · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK

Age, GenelEnvironment Susceptibility-Reykjavik Study Continuation

$1,228,738
Vilmundur Gudnason · Icelandic Heart Association · N01 · FY2012 · AG